LT - Rekombinantinis FSH, įskaitant alfa-2,3- ir alfa-2,6-sialilinimą
EN - RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SIALYLATION
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61P 15/00 |
(2006.01) |
|
|
A61P 15/08 |
(2006.01) |
|
|
C07K 14/59 |
(2006.01) |
|
|
A61K 38/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3144318 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
16194925.0 |
|
Date of filing the European patent application |
2009-04-16 |
| (97) |
Date of publication of the European application |
2017-03-22 |
| (45) |
Date of publication and mention of the grant of the patent |
2020-09-23
|
| (46) |
Date of publication of the claims translation |
2021-02-10
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
45424 P |
2008-04-16
|
US |
|
08251528 |
2008-04-25
|
EP |
Inventors
| (72) |
COTTINGHAM, Ian, CH
PLAKSIN, Daniel, CH
WHITE, Richard Boyd, US
|
Grantee
| (73) |
Ferring B.V.,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Rekombinantinis FSH, įskaitant alfa-2,3- ir alfa-2,6-sialilinimą |
| |
RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SIALYLATION |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2026-04-07 |
18 |
347.00
EUR
|
Next renewal fee
|
2027-04-16 |
